FGF21 and obesity due to melanocortin 4 receptor deficiency: As FGF21 acts as endocrine hormones and take part in the regulation of glucose and lipid metabolism 16, pharmacological application of FGF21 holds great promise as effective therapeutic means for treating NASH), obesity and diabetes17-19.